Lemon Healthcare, a company specializing in real-time two-way medical data brokerage platforms, secured 3.7764 trillion won in subscription deposits from its public offering for retail investors, the company said Tuesday.
The subscription was conducted through KB Securities, the listing's lead underwriter. A total of 755,284,210 shares were received, with the number of subscriptions totaling 313,347. The figures are based on preliminary totals that do not account for duplicate subscription investors. As a result, the subscription competition ratio reached 1,511 to 1. Earlier, Lemon Healthcare set its final offering price at 10,000 won, the top of its target range of 7,500 to 10,000 won, during demand forecasting conducted from the 15th to the 19th of this month.
Lemon Healthcare plans to list on the KOSDAQ market on Dec. 6. The funds raised through the listing will be used to build infrastructure for the distribution and trading of medical data for artificial intelligence (AI) training, to enhance existing services and develop new ones, and to strengthen marketing and brand awareness.
"With the KOSDAQ listing as a catalyst, we will further advance the competitiveness of our medical data brokerage platform and begin building infrastructure for the distribution and trading of medical data for AI training in earnest, establishing ourselves as a company that connects the medical AI ecosystem," Lemon Healthcare CEO Hong Byung-jin said.
